Seed VC · Geneve, Switzerland
Newton Biocapital is a venture capital firm based in Brussels, Belgium, specializing in investments in the life sciences sector, particularly in biotechnology and health-related companies. Established in 2017, the firm focuses on supporting early to mid-stage companies in Europe and Japan that develop innovative solutions for chronic diseases. Newton Biocapital is recognized for its experienced management team and strong network within the biotech industry, contributing to its reputation as a key player in European life sciences investment. The firm has been involved in several notable funding rounds and maintains a portfolio of companies advancing novel therapeutics and medical technologies.
Business models
biotech_therapeutics
Customer segments
Researchers
Geography
Europe, APAC
+ 3 more deals. Score your deck to see the full investment history.
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
NEWTON BIOCAPITAL writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks NEWTON BIOCAPITAL alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. NEWTON BIOCAPITAL is one of them, and we'll tell you exactly where they sit in your top 100.